The Pros and Cons of Investing in Research for Disease Control and Prevention - The Pros and Cons of Investing in Research for Disease Control and Prevention

The Pros and Cons of Investing in Research for Disease Control and Prevention

Even though investing in healthcare services may seem like a straightforward advantage, there are a few factors that need to be considered to ensure that investments are made with the right intentions and that the money goes through the right channels.

Advantages of Investing in Healthcare and Disease Control

The Pros and Cons of Investing in Research for Disease Control and Prevention 2 - The Pros and Cons of Investing in Research for Disease Control and Prevention

When investments are made with the right intentions and transparency, it lowers the risk of money falling into the wrong hands. There should be a clear goal of how the investment will serve the health of the general public.

If the efforts made by healthcare and disease control experts are successful, it lowers the need for healthcare services in general because it will create more awareness about healthcare in the general public. People will also be more inclined to consult a doctor if the investment serves to make clinics more accessible to the general population.

Investments that target the rural populations have a way of helping less fortunate individuals to overcome their health challenges. Healthcare investments can be regulated and monitored by government organisations to ensure that all the relevant health and safety policies are being adhered to.

Disadvantages of Investing in Healthcare and Disease Control

The Pros and Cons of Investing in Research for Disease Control and Prevention 1 - The Pros and Cons of Investing in Research for Disease Control and Prevention

First and foremost, investors need to know exactly where their money goes. Otherwise, it might end up landing in the hands of corrupt people. Illegitimate investment projects can end up costing the government a lot of money.

Healthcare investments need to cater to the concerns and needs of the public, and they should not aim to only serve a selected number of individuals. Equity should always play a central role when it comes to investments in the public health sector.

Some companies that supply health organisations may seek to make a disproportionate profit out of the investment. For example, in some instances, COVID-19 masks were sold at ridiculously high prices, and in the end, the companies or businesses who supplied these masks were making a large profit.

The spread and prevention of disease can only be mitigated by all citizens regardless of status, receiving support from the relevant organisations. Investments should therefore consider the context and how they will contribute to the health of Australian communities.